Cover Image
市場調查報告書

美國未來的生技仿製藥市場商業性可能性

Commercial Potential of the Forthcoming US Biosimilars Market

出版商 Frost & Sullivan 商品編碼 296958
出版日期 內容資訊 英文 156 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國未來的生技仿製藥市場商業性可能性 Commercial Potential of the Forthcoming US Biosimilars Market
出版日期: 2014年02月21日 內容資訊: 英文 156 Pages
簡介

本報告基於Frost & Sullivan對美國著名20名專門醫生召開的討論會(2011年10月11∼13日)的討論內容,提供美國的生技仿製藥的處方情形和今後預測之分析、生技仿製藥對今後美國的醫療市場的短期、中期影響考察,並將結果概述為以下內容。

摘要整理

簡介

背景情況

醫生的處方行動

消費者的購買行動

法規環境

生技仿製藥廠商

附錄

  • 線上討論板的內容

關於Frost&Sullivan

目錄
Product Code: 9837-00-74-00-00

An Addendum to "Specialty Physicians Discuss their Opinions of the United States Biosimilars Market"

Frost & Sullivan assessed physicians' willingness to prescribe biosimilars in the United States. The objective of this research was to conduct a highly qualitative analysis of a representative sample of 20 preselected practicing specialty physicians in the United States in the spirit of an interactive roundtable discussion. The primary goal was to encourage participants to freely express opinions and ideas around all aspects of a topic, facilitating a free exchange about how biosimilars will impact their practice and the overall US healthcare market. The biosimilar research panel was conducted over a three-day period (October 11-13, 2011). Questions and discussions were designed to gauge both short-term and long-term trends and impacts.

Table of Contents

Executive Summary

Introduction

Background Briefing

Physician Prescribing Behavior

Customer Purchasing Behavior

Regulatory Environment

Biosimilar Manufacturers

Appendix

  • Online Discussion Board Transcripts

The Frost & Sullivan Story

Back to Top